BioCentury
ARTICLE | Clinical News

Vigabatrin: Phase I/II data

August 17, 2015 7:00 AM UTC

Top-line data from an open-label, U.S. Phase I/II trial in 4 Tourrette’s disorder patients who were refractory to all other previous treatments showed that 1 patient receiving twice-daily oral vigabat...